253840 fundamentals

Sugentech, Inc. engages in the development, manufacture, and commercializing technologies and products in the areas of multiplex immunoblot, point-of-care test, and digital healthcare based on BIO, NANO, IT, and AI convergence technology. It operates through the following business divisions: Multiplex Immunoblot, On-site Diagnosis, and Digital Healthcare. The Multiplex Immunoblot business division is a lab test product, and an in vitro diagnostic medical device used in diagnostic laboratories such as general hospitals or screening centers. The On-site Diagnosis business division commercializes in vitro diagnostic reagents for COVID-19 rapid antigen diagnostic kits and infectious diseases. The Digital Healthcare business division focuses on products used by general consumers at home. The company was founded by Mi-Jin Sohn, Eun-Kyung Kim, and Seong-Bum Yoo on December 9, 2011 and is headquartered in Daejeon, South Korea.